Webvent

SCRS Sites Directory

Search SCRS member sites. Discover current trials.

AMR Kansas City

Tomorrow's Medicine Today!

AMR Kansas City

The Center for Pharmaceutical Research (CPR) is a privately owned clinical research center specializing in Phase I, II, III, and IV clinical trials for the pharmaceutical, nutraceutical, and medical device industries. 

CPR has two primary missions, each equally important: to provide ethical, safe, cutting-edge medical care for our volunteers and high-quality, clean data to our sponsors with strict adherence to GCP guidelines. 

John E. Ervin, MD, FACP, FACR founded The Center for Pharmaceutical Research in 1986, and serves as the CEO, Medical Director, and Principal Investigator.

The Center for Pharmaceutical Research was audited by the FDA in 1995, 2010, 2013, and 2015 with no findings and no 483’s issued.  Since its inception, CPR has conducted more than 700 trials in most areas of multispecialty research.

Network 

Name Address Country
Alliance for Multispecialty Research, LLC (AMR, LL... 801 N Weisgarber Road Knoxville, Tennessee 37909 United States
Study Search 

  • Phase I, II, III, and IV clinical trials in all areas of multispecialty research.

    Acid Reflux
    Allergy
    Asthma
    Bio-Terrorism Vaccines
    BPH
    Cancer Vaccines
    Constipation
    Dermatology
    Diabetes
    DPN
    Erectile Dysfunction
    Female Sexual Dysfunction
    Fibromyalgia
    High Cholesterol/Lipids
    Hypertension
    Insomnia
    Men’s Health
    Migraine
    Nephrology

    Obesity
    Oral Contraceptive
    Orthopedics
    Osteoarthritis
    Pediatrics
    Pediatric Vaccines
    Phase I Vaccines
    PHN
    Premature Ejaculation
    Psoriasis
    Respiratory
    Rheumatoid Arthritis
    Rosacea
    Seasonal Allergies
    Sleep Disorders
    Smoking Cessation
    Urology
    Vaccines
    Women’s Health


    More Information » www.cprkc.com

Web Site: amrllc.com 

Information

Demographic Data

  • SITE INFORMATION 
  • Start year clinical research1986
  • Phases of clinical studiesPhase I, Phase II, Phase III, Phase IV
  • Types of studiesBiologics, Drugs, Medical Devices, Nutraceuticals, Vaccines
  • PopulationsInfant 0-1yr, Child 2-10 yrs, Adolescent 11-17 yrs, Adult 18-64 yrs, Senior 65 yrs and over
  • SPECIFIC SITE INFORMATION 
  • Type of siteFreestanding
  • # of employees involved in research40
  • # of investigators20
  • Days openMonday, Tuesday, Wednesday, Thursday, Friday, Saturday, Sunday
  • Extended office hoursYes
  • Overnight facilitiesYes
  • Dry iceYes
  • Blinded pharmacistYes
  • Dedicated monitoring spaceYes
  • Internet access for the monitorYes
  • Onsite laboratoryYes
  • Central laboratoryYes
  • Infusion capabilityYes
  • Shipping optionsFedEx, UPS, DHL, Other
  • REGULATORY INFORMATION 
  • Contact for regulatory documentsLaura Mitchell
  • Regulatory phone number816-943-0770
  • # of days to turn around regulatory documents5
  • Type of IRB used by this siteCentral
  • Appropriate storage facilities for productYes
  • Able to appropriately store Schedule II drugsYes
  • FINANCIAL INFORMATION 
  • # days to turn around budget and contractless than 10 working days

Contact

  • Jason Huntington

    Director of Business Development
    Center for Pharmaceutical Research
    Kansas City, Missouri